0IIM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Esperion Therapeutics Inc

Watchlist Manager

Watchlist

Price: 3.1123 USD 52.71% Market Closed

Market Cap: $744m

	Esperion Therapeutics Inc LSE:0IIM	US
C	CIR SpA - Compagnie Industriali Riunite LSE:0ONR	IT
E	Entest Group Inc OTC:ETNI	CN
S	Sofina SA LSE:0G2X	BE
	Almirall SA LSE:0O9B	ES
	Heidelberger Beteiligungsholding AG F:IPOK	DE
F	Franklin Resources Inc BMV:BEN	US

Profitability Summary

Esperion Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

61% > 68%

Healthy Operating Margin

15%

Negative 3Y Average Operating Margin

-62%

Operating Margin is Increasing

-229% > 15%

Negative Net Margin

-6%

Negative 3Y Average Net Margin

-99%

Net Margin is Increasing

-295% > -6%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-69%

Free Cash Flow Margin is Increasing

-235% > -3%

Low ROE

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-70%

ROIC is Increasing

-218% > 34%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.